Latest filing published 07 Jul 2026 for uniQure N.V., €358k. Read the official filing
This profile gathers the share dealings of Matthew C. Kapusta across 2 companies, led by uniQure N.V. and Decibel Therapeutics, Inc. Over a trading history stretching from 4 January 2018 to 2 July 2026, the count stands at 121 filings.
No open-market purchase appears, only 95 sales worth €23.1M. The rest of the record consists of 14 share grants and 11 option exercises. 2026 to date brings no purchases and 7 sales.
On 7 July 2026 came the latest disclosure, an open-market sale for €358k in uniQure N.V. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 120 declarations